Literature DB >> 30028263

Therapeutic strategy for pineal parenchymal tumor of intermediate differentiation (PPTID): case report of PPTID with malignant transformation to pineocytoma with leptomeningeal dissemination 6 years after surgery.

Toshiaki Bando1, Yasushi Ueno1, Narihide Shinoda1, Yukihiro Imai2, Kazuhito Ichikawa3, Yoji Kuramoto1, Takahiro Kuroyama1, Daisuke Shimo1, Kazuyuki Mikami1, Shinya Hori1, Masato Matsumoto1, Osamu Hirai1.   

Abstract

Pineal parenchymal tumor of intermediate differentiation (PPTID) is rare. The WHO first classified PPTID in 2000 as a pineal parenchymal tumor (PPT) with an intermediate prognosis between pineocytoma (PC) and pineoblastoma (PB). It is considered an intermediate-grade tumor and divided into WHO grade II or III.The number of available reports about PPTID is presently limited, and the appropriate management for this tumor has not yet been determined.The authors report a rare case of PC in a 63-year-old woman who presented with lower-extremity weakness and gait disturbance. A pineal mass lesion was detected on MRI. A diagnosis of PC was established after microsurgical gross-total tumor resection, and the patient received no adjuvant therapy after surgery. Two years after surgery, a partial recurrence was recognized and Gamma Knife radiosurgery was performed. Fours years later, the patient developed diffuse leptomeningeal dissemination. She was successfully treated with craniospinal irradiation. Leptomeningeal dissemination may develop 6 years after the initial diagnosis of PC. A histopathological study of the recurrent tumor revealed a malignant change from PC to PPTID.The present case shows the importance of long-term follow-up of patients with PPTs following resection and the efficacy of craniospinal irradiation in the treatment of leptomeningeal dissemination.

Entities:  

Keywords:  NCAM = neural cell adhesion molecule; PB = pineoblastoma; PC = pineocytoma; PPT = pineal parenchymal tumor; PPTID = PPT of intermediate differentiation; SRS = stereotactic radiosurgery; leptomeningeal dissemination; oncology; pineal parenchymal tumor of intermediate differentiation

Year:  2018        PMID: 30028263     DOI: 10.3171/2018.2.JNS171876

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  4 in total

1.  Prognosticating survival of pineal parenchymal tumors of intermediate differentiation (PPTID) by grade.

Authors:  Victor M Lu; Evan M Luther; Daniel G Eichberg; Alexis A Morell; Ashish H Shah; Ricardo J Komotar; Michael E Ivan
Journal:  J Neurooncol       Date:  2021-10-04       Impact factor: 4.130

2.  Role of Hypofractionated Stereotactic Radiosurgery in Recurrent Pineal Parenchymal Tumors of Intermediate Differentiation: A Case Report and Review of the Literature.

Authors:  Caglayan Selenge Beduk Esen; Gozde Yazici; Mustafa Berker; Faruk Zorlu
Journal:  Cureus       Date:  2020-08-13

Review 3.  Supratentorial Pediatric Midline Tumors and Tumor-like Lesions: Clinical Spectrum, Natural History and Treatment Options.

Authors:  Luca Paun; Alexandre Lavé; Gildas Patet; Andrea Bartoli
Journal:  Children (Basel)       Date:  2022-04-09

Review 4.  Pineal Gland Tumors: A Review.

Authors:  Gaia Favero; Francesca Bonomini; Rita Rezzani
Journal:  Cancers (Basel)       Date:  2021-03-27       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.